ATE298766T1 - Veränderung der herstellung von alpha-interferon - Google Patents
Veränderung der herstellung von alpha-interferonInfo
- Publication number
- ATE298766T1 ATE298766T1 AT99965674T AT99965674T ATE298766T1 AT E298766 T1 ATE298766 T1 AT E298766T1 AT 99965674 T AT99965674 T AT 99965674T AT 99965674 T AT99965674 T AT 99965674T AT E298766 T1 ATE298766 T1 AT E298766T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrrolidinone
- methyl
- aliphatic
- production
- cyclic
- Prior art date
Links
- 102000006992 Interferon-alpha Human genes 0.000 title 1
- 108010047761 Interferon-alpha Proteins 0.000 title 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 210000000265 leukocyte Anatomy 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 abstract 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 abstract 2
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 abstract 1
- NPGFWOWMRXCXKF-UHFFFAOYSA-N 1-ethylpyrrolidin-2-one;4-methylpentan-2-one Chemical compound CC(C)CC(C)=O.CCN1CCCC1=O NPGFWOWMRXCXKF-UHFFFAOYSA-N 0.000 abstract 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 abstract 1
- ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical class OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 abstract 1
- YCIPQJTZJGUXND-UHFFFAOYSA-N Aglaia odorata Alkaloid Natural products C1=CC(OC)=CC=C1C1(C(C=2C(=O)N3CCCC3=NC=22)C=3C=CC=CC=3)C2(O)C2=C(OC)C=C(OC)C=C2O1 YCIPQJTZJGUXND-UHFFFAOYSA-N 0.000 abstract 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 150000008431 aliphatic amides Chemical class 0.000 abstract 1
- 150000008365 aromatic ketones Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003950 cyclic amides Chemical class 0.000 abstract 1
- -1 cyclic sulfoxides Chemical class 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
- 229940113082 thymine Drugs 0.000 abstract 1
- 229940075420 xanthine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9804583A SE513313C2 (sv) | 1998-12-29 | 1998-12-29 | Modifierad interferonproduktion |
| PCT/SE1999/002446 WO2000039163A1 (en) | 1998-12-29 | 1999-12-22 | Modification of interferon alpha production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298766T1 true ATE298766T1 (de) | 2005-07-15 |
Family
ID=20413894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99965674T ATE298766T1 (de) | 1998-12-29 | 1999-12-22 | Veränderung der herstellung von alpha-interferon |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6962695B1 (de) |
| EP (1) | EP1141012B1 (de) |
| JP (1) | JP4584456B2 (de) |
| AT (1) | ATE298766T1 (de) |
| AU (1) | AU2136200A (de) |
| CA (1) | CA2354025C (de) |
| CZ (1) | CZ301888B6 (de) |
| DE (1) | DE69926013T2 (de) |
| ES (1) | ES2244239T3 (de) |
| HK (1) | HK1040086B (de) |
| HU (1) | HU227164B1 (de) |
| NO (1) | NO328424B1 (de) |
| PT (1) | PT1141012E (de) |
| SE (1) | SE513313C2 (de) |
| WO (1) | WO2000039163A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE513313C2 (sv) * | 1998-12-29 | 2000-08-21 | Bionative Ab | Modifierad interferonproduktion |
| JP2009298752A (ja) * | 2008-06-17 | 2009-12-24 | Shiseido Co Ltd | 皮膚外用剤組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932617A (en) * | 1974-05-24 | 1976-01-13 | The Upjohn Company | Interferon induction |
| US4027021A (en) | 1974-08-23 | 1977-05-31 | The Upjohn Company | Interferon induction |
| CS215108B2 (en) | 1977-07-15 | 1982-07-30 | Wellcome Found | Method of making the interferrone |
| EP0005476B1 (de) | 1978-05-17 | 1981-12-30 | Dr. Karl Thomae GmbH | Verfahren zur Herstellung von Humaninterferon |
| JPS56135420A (en) * | 1980-03-26 | 1981-10-22 | Fumiaki Taguchi | Suppressive substance of virus and its preparation |
| IT1172270B (it) * | 1982-06-21 | 1987-06-18 | Wellcome Found | Procedimento per la produzione di interferon |
| SE513313C2 (sv) * | 1998-12-29 | 2000-08-21 | Bionative Ab | Modifierad interferonproduktion |
-
1998
- 1998-12-29 SE SE9804583A patent/SE513313C2/sv not_active IP Right Cessation
-
1999
- 1999-12-22 AT AT99965674T patent/ATE298766T1/de active
- 1999-12-22 CZ CZ20011951A patent/CZ301888B6/cs not_active IP Right Cessation
- 1999-12-22 AU AU21362/00A patent/AU2136200A/en not_active Abandoned
- 1999-12-22 EP EP99965674A patent/EP1141012B1/de not_active Expired - Lifetime
- 1999-12-22 WO PCT/SE1999/002446 patent/WO2000039163A1/en not_active Ceased
- 1999-12-22 PT PT99965674T patent/PT1141012E/pt unknown
- 1999-12-22 US US09/869,269 patent/US6962695B1/en not_active Expired - Fee Related
- 1999-12-22 CA CA2354025A patent/CA2354025C/en not_active Expired - Fee Related
- 1999-12-22 JP JP2000591074A patent/JP4584456B2/ja not_active Expired - Fee Related
- 1999-12-22 DE DE69926013T patent/DE69926013T2/de not_active Expired - Lifetime
- 1999-12-22 HU HU0104761A patent/HU227164B1/hu not_active IP Right Cessation
- 1999-12-22 HK HK02101764.0A patent/HK1040086B/en not_active IP Right Cessation
- 1999-12-22 ES ES99965674T patent/ES2244239T3/es not_active Expired - Lifetime
-
2001
- 2001-06-28 NO NO20013243A patent/NO328424B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0104761A2 (hu) | 2002-04-29 |
| JP2002533112A (ja) | 2002-10-08 |
| CA2354025A1 (en) | 2000-07-06 |
| EP1141012A1 (de) | 2001-10-10 |
| CA2354025C (en) | 2012-05-22 |
| DE69926013D1 (de) | 2005-08-04 |
| SE9804583L (sv) | 2000-06-30 |
| AU2136200A (en) | 2000-07-31 |
| WO2000039163A1 (en) | 2000-07-06 |
| EP1141012B1 (de) | 2005-06-29 |
| DE69926013T2 (de) | 2006-05-18 |
| NO328424B1 (no) | 2010-02-15 |
| HK1040086B (en) | 2006-01-20 |
| JP4584456B2 (ja) | 2010-11-24 |
| HU227164B1 (en) | 2010-09-28 |
| HK1040086A1 (en) | 2002-05-24 |
| ES2244239T3 (es) | 2005-12-01 |
| SE513313C2 (sv) | 2000-08-21 |
| US6962695B1 (en) | 2005-11-08 |
| CZ20011951A3 (cs) | 2002-02-13 |
| HUP0104761A3 (en) | 2004-07-28 |
| NO20013243D0 (no) | 2001-06-28 |
| NO20013243L (no) | 2001-06-28 |
| SE9804583D0 (sv) | 1998-12-29 |
| PT1141012E (pt) | 2006-06-30 |
| CZ301888B6 (cs) | 2010-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9913406A (pt) | Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção | |
| EP0653439A3 (de) | Stabilisierte Oligonucleotide und deren Verwendung. | |
| BR9814374A (pt) | Inibição de quinase raf usando uréias heterocìclicas substituìdas | |
| HRP20050417B1 (hr) | Antiviralni derivati nukleozida | |
| EA200000840A1 (ru) | Антивирусные производные пиримидина | |
| DE60143672D1 (de) | Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation | |
| ATE134644T1 (de) | Weitere antivirale pyrimidin-nukleosiden | |
| DE69839557D1 (de) | Klonierte genome von infektiösen hepatitis c viren und deren verwendungen | |
| ATE355380T1 (de) | Methode zur selektiven inaktivierung der viralen replication | |
| NO930059L (no) | O-glykosylert ifn-alfa | |
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| PT97754A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo pelo menos um agente inibidor da poli-(adp-ribose)-polimerase nomeadamente, uma amida aromatica, para o tratamento de infeccoes provocadas por virus | |
| DE69627035D1 (de) | Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren | |
| CY1105344T1 (el) | Αμινουχα παραγωγα της διυδρο- 1,3,5 - τριαζινης και οι εφαρμογες τους στη θepαπευτικη | |
| DE60039729D1 (de) | N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen | |
| ES2189404T3 (es) | 1,3,4-tiadiazoles utiles para el tratamiento de infecciones por cmv. | |
| DE69932154D1 (de) | Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen | |
| DE69110854D1 (de) | Antivirusderivate von (Phosphonmethoxy)Methoxy Purin/Pyrimidin. | |
| ATE295732T1 (de) | Verwendung von n-substituierten 1,5-dideoxy-1,5- imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen | |
| ATE281179T1 (de) | Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür | |
| EA200600046A1 (ru) | Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции | |
| ATE298766T1 (de) | Veränderung der herstellung von alpha-interferon | |
| ATE77234T1 (de) | Aromatische verbindungen mit amider struktur, derivate von aminobenzoesaeuren, hydroxybenzoesaeuren, zimtsaeuren, urocansaeuren und benzimidazolen, die uvb und/oder uva absorbieren. | |
| EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
| DE69927251D1 (de) | Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1141012 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |